We are live on
!
Find out more
OAM
Oppenheimer Asset Management Portfolio holdings
AUM
$8.76B
1-Year Est. Return
23.12%
This Fund
S&P 500
This Quarter
Est. Return
+2.96%
1 Year Est. Return
+23.12%
3 Year Est. Return
+69.23%
5 Year Est. Return
+84.02%
10 Year Est. Return
+273.29%
AUM
$3.62B
AUM Growth
+$109M
(+3.1%)
Cap. Flow
+$29.8M
Cap. Flow
% of AUM
0.82%
Top 10 Holdings %
Top 10 Hldgs %
13.63%
Holding
1,787
New
81
Increased
723
Reduced
742
Closed
106
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson Controls International
JCI
|
+$9.09M |
| 2 |
General Mills
GIS
|
+$8.3M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$8.22M |
| 4 |
Cencora
COR
|
+$4.97M |
| 5 |
iShares Core S&P Small-Cap ETF
IJR
|
+$4.77M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$7.8M |
| 2 |
DNB
Dun & Bradstreet
DNB
|
+$6.42M |
| 3 |
PNC Financial Services
PNC
|
+$6.23M |
| 4 |
PepsiCo
PEP
|
+$5.76M |
| 5 |
Walt Disney
DIS
|
+$4.56M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 15.38% |
| 2 | Healthcare | 15.13% |
| 3 | Technology | 14.47% |
| 4 | Industrials | 12.84% |
| 5 | Consumer Discretionary | 8.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HBP
1401
DELISTED
Huttig Building Products, Inc.
HBP
| $31K | ﹤0.01% |
4,490
+3,216
| +252% | +$23.6K |
|
1402
Avnet
AVT
$7.25B
| $30K | ﹤0.01% |
773
-126
| -14% | -$4.99K |
|
1403
Exelon
EXC
$46.9B
| $30K | ﹤0.01% |
1,148
-304
| -21% | -$7.74K |
|
1404
iShares International Select Dividend ETF
IDV
$8.45B
| $30K | ﹤0.01% |
920
-228
| -20% | -$7.39K |
|
1405
Lee Enterprises
LEE
$179M
| $30K | ﹤0.01% |
1,577
+1,120
| +245% | +$25.1K |
|
1406
OceanFirst Financial
OCFC
$1.7B
| $30K | ﹤0.01% |
1,118
| – | – |
|
|
SAGE
1407
DELISTED
Sage Therapeutics
SAGE
| $30K | ﹤0.01% |
379
-4
| -1% | -$289 |
|
1408
Simulations Plus
SLP
$371M
| $30K | ﹤0.01% |
2,401
+976
| +68% | +$11.6K |
|
|
LKSD
1409
DELISTED
LSC Communications, Inc.
LKSD
| $30K | ﹤0.01% |
1,394
-191
| -12% | -$4.36K |
|
1410
iShares MSCI Germany ETF
EWG
$1.6B
| $28K | ﹤0.01% |
910
+21
| +2% | +$634 |
|
1411
Ingevity
NGVT
$2.53B
| $28K | ﹤0.01% |
491
+71
| +17% | +$4.18K |
|
1412
SiteOne Landscape Supply
SITE
$4.28B
| $28K | ﹤0.01% |
537
-92
| -15% | -$4.58K |
|
1413
Sony
SONY
$133B
| $28K | ﹤0.01% |
3,690
-290
| -7% | -$2.06K |
|
1414
WD-40
WDFC
$3.06B
| $28K | ﹤0.01% |
258
+4
| +2% | +$426 |
|
|
AGU
1415
DELISTED
Agrium
AGU
| $28K | ﹤0.01% |
306
+24
| +9% | +$2.22K |
|
|
DRD
1416
DRDGold
DRD
$1.81B
| $27K | ﹤0.01% |
8,606
| – | – |
|
1417
Forum Energy Technologies
FET
$791M
| $27K | ﹤0.01% |
87
| – | – |
|
|
MAGN
1418
Magnera Corp
MAGN
$488M
| $27K | ﹤0.01% |
105
+32
| +44% | +$8.15K |
|
1419
L3Harris
LHX
$51.4B
| $26K | ﹤0.01% |
240
-2,952
| -92% | -$325K |
|
|
SWNC
1420
DELISTED
Southwestern Energy Company
SWNC
| $26K | ﹤0.01% |
1,777
| – | – |
|
|
ATSG
1421
DELISTED
Air Transport Services Group
ATSG
| $25K | ﹤0.01% |
1,138
-12
| -1% | -$251 |
|
|
XLRN
1422
DELISTED
Acceleron Pharma
XLRN
| $25K | ﹤0.01% |
837
-12
| -1% | -$348 |
|
1423
Puma Biotechnology
PBYI
$381M
| $24K | ﹤0.01% |
273
-150
| -35% | -$8.39K |
|
|
PARA
1424
DELISTED
Paramount Global Class B
PARA
| $23K | ﹤0.01% |
365
-9,973
| -96% | -$638K |
|
|
TXNM
1425
TXNM Energy Inc
TXNM
$6.37B
| $22K | ﹤0.01% |
581
-52
| -8% | -$1.98K |
|
Similar funds
SWP
MOACM
MERSOM
MU
MC
PCIA
PEA
HI
Oppenheimer Asset Management's Q2 2017 Portfolio in Review
As of Q2 2017, Oppenheimer Asset Management held 1,787 positions worth $3.62B, up 3.1% from $3.51B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Oppenheimer Asset Management's Q2 2017 filing shows 81 new, 723 increased, 742 reduced and 106 closed positions. Its largest new stake was Evolent Health: 58,930 shares worth $1.49M. The largest sale was Microsoft, an estimated $7.8M.
By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 15% a quarter earlier, followed by Healthcare and Technology.
- Oppenheimer Asset Management's largest Q2 2017 buy was Evolent Health: 58,930 shares worth $1.49M.
- Oppenheimer Asset Management added most to Johnson Controls International in Q2 2017, an estimated $9.09M increase.
- Oppenheimer Asset Management's biggest Q2 2017 reduction was Microsoft, cutting an estimated $7.8M.
- Oppenheimer Asset Management fully exited Nippon Telegraph & Telephone in Q2 2017, selling an estimated $3.36M.
- Oppenheimer Asset Management's ten largest holdings make up 14% of its $3.62B portfolio in Q2 2017.
- Oppenheimer Asset Management opened 81 new positions and closed 106 in Q2 2017.
- Oppenheimer Asset Management's portfolio value rose 3.1% quarter-over-quarter to $3.62B.
Based on Oppenheimer Asset Management's 13F filing for Q2 2017, filed 9 Aug 2017.